Skip to content

Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee

Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04952220
Acronym
USAK
Enrollment
30
Registered
2021-07-07
Start date
2021-10-27
Completion date
2025-10-31
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthritis, Septic Arthritis, Ultrasound Therapy; Complications

Brief summary

Primary objective: Description of ultrasound abnormalities seen in native septic arthritis of the knee during each visit. Primary endpoint: Describe the ultrasound abnormalities observed on Day 0, Day 10, 6 weeks, 3 months, 6 months, during native septic arthritis of the knee.

Detailed description

Secondary Objectives: 1. Search for poor prognostic factors in native septic arthritis of the knee. 2. To look for an association between initial sonographic factors and the use of joint lavage. 3. Look for associations between sonographic signs and clinico-radio-biologic factors at each visit (D10, 6 weeks, 3 months and 6 months)

Interventions

DEVICEultrasound

Describe the sonographic abnormalities observed at Day 0, Day 10, 6 weeks, 3 months, 6 months, during native septic arthritis of the knee

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female of legal age * Bacteriologically proven native septic arthritis * Meets the definition of septic arthritis: Bacteriological documentation of joint puncture fluid-Native articulation * Free subject, without guardianship or trusteeship, or subordination * Non-opposition of the patient after clear and fair information about the study

Exclusion criteria

* Presence of material in the affected joint * Arthritis with Mycobacterium Tuberculosis. * Patients benefiting from a reinforced protection, namely: minors, pregnant and/or breast-feeding women, persons deprived of liberty by a judicial or administrative decision, adults under legal protection

Design outcomes

Primary

MeasureTime frameDescription
description of the ultrasound abnormalities seen in native septic arthritis of the kneeDay0, Day 10 or before surgery, 6week, 3months, 6monthsDescribe the ultrasonographic abnormalities seen in native septic arthritis of the knee

Countries

France

Contacts

Primary ContactGERVAIS Elisabeth
elisabeth.gervais@chu-poitiers.fr05 49 44 44 65

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026